X-154032268-G-C
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_001110792.2(MECP2):c.352C>G(p.Arg118Gly) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R118L) has been classified as Likely pathogenic.
Frequency
Consequence
NM_001110792.2 missense
Scores
Clinical Significance
Conservation
Publications
- chromosome Xq28 duplication syndromeInheritance: XL Classification: DEFINITIVE Submitted by: G2P
- Rett syndromeInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics, ClinGen, G2P
- severe neonatal-onset encephalopathy with microcephalyInheritance: XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
- syndromic X-linked intellectual disability Lubs typeInheritance: XL Classification: DEFINITIVE Submitted by: G2P
- atypical Rett syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- non-syndromic X-linked intellectual disabilityInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
- X-linked intellectual disability-psychosis-macroorchidism syndromeInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
- systemic lupus erythematosusInheritance: Unknown Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 25
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 25
ClinVar
Submissions by phenotype
Rett syndrome Pathogenic:1Uncertain:1
This variant has been collected from RettBASE and curated to current modified ACMG/AMP criteria. Based on the classification scheme defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders Specifications to the ACMG/AMP Variant Interpretation Guidelines VCEP 3.0, this variant is classified as likely pathogenic. At least the following criteria are met: Occurs in the well-characterized Methyl-DNA binding (MDB) functional domain of MECP2 (PM1). Has been observed in at least 3 individuals with phenotypes consistent with MECP2-related disease(PS4_Moderate). (PMID: 16473305, 16183801) Computational prediction analysis tools suggests a deleterious impact (REVEL score>= 0.75) (PP3). This variant is absent from gnomAD (PM2_Supporting).
MECP2-related disorder Pathogenic:1
The MECP2 c.316C>G variant is predicted to result in the amino acid substitution p.Arg106Gly. This variant has been reported in at least 4 affected individuals with a Rett syndrome phenotype. However, at least one unaffected female was identified to be heterozygous for the variant (Proband ID 2195; http://mecp2.chw.edu.au/mecp2/mecp2_variant_page.php?&id=2194; http://mecp2.chw.edu.au/mecp2/mecp2_variant_page.php?&id=2194; Philippe et al. 2006. PubMed ID: 16473305; Bienvenu et al. 2002. PubMed ID: 12180070). X chromosome inactivation is thought to contribute to phenotypic variability in females (Knudsen et al. 2006. PubMed ID: 16823396; Fang et al. 2022. PubMed ID: 35318820). Furthermore, several other missense variants impacting the same amino acid residue (p.Arg106Trp, p.Arg106Gln, p.Arg106Leu) have been reported in individuals with Rett syndrome phenotypes (http://mecp2.chw.edu.au/mecp2/mecp2_upgrade_proband_list_copy.php). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. Take together, this variant is interpreted as likely pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at